Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade | Blood | American Society of Hematology
You do not currently have access to this content.
Related Articles
Deletions in the MAL gene result in loss of Mal protein, defining the rare inherited AnWj-negative blood group phenotype
Key Points. The inherited AnWj-negative blood group phenotype is caused by homozygosity for a deletion in MAL, encoding Myelin and lymphocyte proteinMal pr
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies
Key PointsCAR-37 T cells expanded to >98% of T cells and led to complete responses but caused severe cytopenia associated with high levels of IL-18.Depl
Therapy response in AML: a tale of two T cells
In this issue of Blood, Mazziotta et al1 investigate CD8+ T-cell subpopulations as correlates with response to induction chemotherapy in acute myeloid leuk
Bone marrow vexations
In this issue of Blood, Sirenko et al1 report the prevalence of UBA1 mutations in 2 cohorts of patients with myelodysplastic syndrome (MDS) and demonstrate
A Phase 1 Clinical Trial of NKTR-255 with CD19-22 CAR-T Cell Therapy for Refractory B-cell Acute Lymphoblastic Leukemia
Key Points. Combining CAR-T cells targeting CD19 & CD22 with a recombinant, polymer-conjugated IL15 receptor agonist (NKTR-255) was safe and feasible.2
ATM kinase rheostA-T impacts cancer outcomes
In this issue of Blood, Elitzur et al1 investigate the outcomes of hematologic malignancies in individuals with ataxia-telangiectasia (A-T) by conducting a
Clinical outcomes after idecabtagene vicleucel in older patients with multiple myeloma: a multicenter real-world experience
Key PointsThe safety and efficacy benefits of ide-cel were proportionate in young and older patients despite frailty and geriatric characteristics.Treatmen
Therapy response in AML: a tale of two T cells
In this issue of Blood, Mazziotta et al1 investigate CD8+ T-cell subpopulations as correlates with response to induction chemotherapy in acute myeloid leuk
T-cell dysfunction in CLL is mediated through expression of Siglec-10 ligands CD24 and CD52 on CLL cells
Key PointsThe presence of CLL cells delays T-cell receptor–mediated CAR T-cell activation and impairs proliferation and restimulation.Blocking CD24 and CD5
The rules of T-cell engagement: current state of CAR T cells and bispecific antibodies in B-cell lymphomas
Abstract. T-cell engaging–therapies have transformed the treatment landscape of relapsed and refractory B-cell non-Hodgkin lymphomas by offering highly eff
